EGFR and ductal breast carcinoma in situ: In our study, pathways leading to TACE-dependent EGFR signalling pathways were more observant; specifically, MAPK signalling pathways, GPCR signalling pathways, and toll-like receptor pathways in DCIS, grade 2 and grade 3.